Andrés JM Ferreri - Concepedia

Author

Andrés JM Ferreri

The University of Texas MD Anderson Cancer Center

Also Known As

A. J.M. Ferreri, Andres JM Ferreri, Andrés JM Ferreri, Andrés J M Ferreri, Andrés J. M. Ferreri, Andrés JM Ferreri

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center San Raffaele University of Rome Ospedale San Bortolo Istituti di Ricovero e Cura a Carattere Scientifico Radboud University Medical Center

About

Andrés JM Ferreri is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	874
2	Pathology	4	4	218
3	Immunology	3	3	208
4	Health Sciences	1	1	656
5	Neuro-oncology	1	1	656

Andrés JM Ferreri

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial Andrés JM Ferreri, Michele Reni, Marco Foppoli, The Lancet Hematological MalignancyNeuro-oncologyLymphoid NeoplasiaMedicinePrimary Cns Lymphoma	2009	656
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions Andrés JM Ferreri, Giuseppina Dognini, Elı́as Campo, Haematologica	2007	182
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP Alexandar Tzankov, Zijun Y. Xu‐Monette, Marc Gerhard, Modern Pathology Hematological MalignancyLymphoid NeoplasiaMedicineMalignant Blood DisorderImmunology	2013	128
Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP Zijun Y. Xu‐Monette, Bouthaina S. Dabaja, Xiaoxiao Wang, Modern Pathology Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyMyc Rearrangement	2015	54
Association betweenHelicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications Andrés JM Ferreri, Maurilio Ponzoni, Edi Viale, Hematological Oncology	2005	46
Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy Zhiyu Liu, Zijun Y. Xu‐Monette, Xin Cao, Modern Pathology Lymphoid NeoplasiaMedicineImmunologyPathologyRituximab-chop Therapy	2015	26
Efficacy and Safety of Tisagenlecleucel in Adult Patients with Relapsed/Refractory Follicular Lymphoma: Interim Analysis of the Phase 2 Elara Trial Nathan Fowler, Michael Dickinson, Martin Dreyling, Blood	2020	24
Safety, Tolerability and Activity of Ofatumumab, Bendamustine and Dexamethasone Combination As First-Line Treatment of Mantle-Cell Lymphoma in the Elderly: A Multicenter Study Michele Magni, Massimo Di Nicola, Carmelo Carlo‐Stella, Blood	2011	16
Efficacy of Tisagenlecleucel in Adult Patients (Pts) with High-Risk Relapsed/Refractory Follicular Lymphoma (r/r FL): Subgroup Analysis of the Phase II Elara Study Catherine Thiéblemont, Michael Dickinson, Joaquín Martínez‐López, Blood	2021	15
The impact of histopathologic diagnosis on the proper management of testis neoplasms Giovanni Ponti, Maurilio Ponzoni, Andrés JM Ferreri, Nature Clinical Practice Oncology Histopathologic DiagnosisProper ManagementTestis NeoplasmsHistopathologyDiagnosis	2008	10

Page 1